Australian advantage

Accelerate your clinical development in Australia

Australian-based bioanalysis for globally focused clinical programs

From Melbourne, Crux Biolabs supports sponsors with tailored bioanalytical services for clinical studies conducted in Australia and beyond. Combine responsive scientific partnership with a streamlined clinical-trial environment and R&D tax incentives to help advance your program with confidence.

Talk to our experts

Extend your R&D runway in Australia

Potentially access up to 43.5% cash back through the Australian R&D Tax Incentive

Eligible companies undertaking qualifying R&D activities in Australia may be able to access a refundable tax offset of up to 43.5 percent. The outcome depends on factors including company turnover, eligible expenditure and the nature of the activities.

As a registered Research Service Provider, Crux Biolabs can provide the bioanalytical support and service documentation you need for discussions with your R&D tax adviser.

The benefit

When eligible bioanalytical work is undertaken in Australia, it may contribute to your qualifying Australian R&D expenditure and help maximise the value of your R&D Tax Incentive claim.

The process

Engage Crux Biolabs early in your study planning so your bioanalytical work is scoped, delivered and documented clearly. We will work closely with your team to provide the information you need for discussions with your R&D tax adviser. This allows you to remain focused on the science.

Why conduct your study in Australia?

Streamlined clinical trial pathways

Australia’s Clinical Trial Notification scheme provides a nationally recognised pathway for eligible clinical trials. Ethics approval and site or institutional authorisation form part of the pathway, with timelines shaped by study complexity and participating sites.

  • 4-6 weeks typical ethics review
  • Under 12 weeks start-up

Established clinical research environment

Australia offers an established clinical-research sector and a regulatory environment that supports globally focused development programs. Crux provides tailored bioanalytical support aligned to your study objectives, assay requirements and operational timelines.

Internationally aligned quality and data

Australia’s established clinical research environment supports the generation of high-quality data for globally focused development programs. Clinical research is conducted within recognised regulatory and ethical frameworks, with quality systems designed to support robust, reliable and well-documented study data. This alignment with international quality standards helps sponsors generate data that can support clinical development and regulatory activities across global markets.

Australian bioanalysis, clearly documented

Crux Biolabs delivers bioanalytical services from its Melbourne facility. As a registered Research Service Provider (RSP), we can provide relevant service documentation to support discussions with your qualified R&D tax adviser. Engage us early so the bioanalytical component of your study is scoped and documented clearly.